24-Month Phase I/II Clinical Trial of Bimatoprost Sustained-Release Implant (Bimatoprost SR) in Glaucoma Patients

Craven, ER; Walters, T; Christie, WC; Day, DG; Lewis, RA; Goodkin, ML; Chen, M; Wangsadipura, V; Robinson, MR; Bejanian, M; Aung, T; Beck, AD; Branch, JD; Christie, WC; Coote, M; Crane, CJ; Craven, ER; Crichton, A; Day, DG; Day, S; Durcan, FJ; Evans,

Craven, ER (reprint author), Johns Hopkins Univ, Sch Med, 600 N Wolfe St,110, Baltimore, MD 21287 USA.

DRUGS, 2020; 80 (2): 167

Abstract

Objective The objective of this study was to evaluate the safety and intraocular pressure (IOP)-lowering effects over 24 months of biodegradable bimat......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索